Genesys Teams up With Agfa Spinoff
PACS firm Genesys and compact video camera manufacturer VisiplexInstruments have inked a joint marketing agreement to sell eachother's products on a global basis. The new alliance was evidentat last month's RSNA meeting, where Visiplex demonstrated
PACS firm Genesys and compact video camera manufacturer VisiplexInstruments have inked a joint marketing agreement to sell eachother's products on a global basis. The new alliance was evidentat last month's RSNA meeting, where Visiplex demonstrated Genesysproducts at its booth.
The agreement is good way for both companies to play off eachother's strengths when competing with larger firms, accordingto William Greenblatt, Genesys vice president of sales.
"Even with a PAC system, you still need output peripherals,"Greenblatt said. "Genesys is a smaller company, and it makessense for us to diversify."
Visiplex was formed last July when executives at Agfa's Orangeburg,NY, facility purchased the former Matrix compact camera businessfrom Agfa (SCAN 7/14/93).
Since the purchase, Visiplex has introduced two new compactcameras. CCM601 is an ultrasound camera in both gray-scale andcolor for 4 on 1 and 6 on 1 formats. CCM650 is an ultra-high-resolutioncamera for nuclear medicine and C-arm applications. Both camerashave Food and Drug Administration marketing clearance.
Genesys, of Orlando, FL, displayed new MRI viewing softwareat the Visiplex booth. The works-in-progress software runs onan Imlogix workstation and enables clinicians to view MRI slicessimultaneously. Genesys purchased Imlogix in 1992 (SCAN 12/30/92).
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
